Amount$5M
SeriesSeries A
AnnouncedMar 9, 2022
Time since last round277 mo
SectorLife Sciences, Immunotherapy, Immunology, Cancer, Cancer Immunotherapy, Antibody
Sub-sectorArtificial Intelligence
Mixed
A mixed round — some signals are off the norm.
Round size vs peers
Smaller than the typical Series A round.
Syndicate size
Single investor — limited external validation.
Insider conviction
All-new money — no prior investors re-upped.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series A rounds (995)
Round size distribution16th pct
smaller Series A roundslarger
vs. Life Sciences, Immunotherapy, Immunology, Cancer, Cancer Immunotherapy, Antibody (6)
Round size in sector33th pct
$3Mthis round: $5M$25M